The purpose of the VIPS study is to learn more about childhood ischemic stroke. It is hypothesized that infections and the body’s reaction to it can play a role in the occurrence of a stroke.
The first VIPS study took place between 2010-2012 with 355 paediatric stroke cases and 354 controls enrolled from 39 centres. It helped us better understand the relationship between infections and childhood stroke. We found that:
- Minor childhood infections can act as a trigger for a stroke, especially in children who have some other reason for stroke, like a heart abnormality.
- The infections that occur right before a childhood stroke are mostly just the common cold.
- Blood tests for a family of viruses called herpesviruses showed that many children with stroke had the herpes simplex virus type 1. The herpes simplex virus type 1 is the cause of cold sores. Most of the herpesvirus infections were “subclinical”, meaning the child did not have cold sores or any other outward signs of infection.
- Routine childhood vaccinations seem to help protect children against stroke.
However, infections are so common in children, but stroke is so rare. How does this add up? This question is why the VIPS study was extended to Part 2. In VIPS II, blood samples and throat swabs are collected from our study participants to detect the bugs that are infecting children with stroke and to study their inflammatory response.
VIPS II began enrolling participants in December 2016 and will continue until 2021. The goal is to enroll 200 acute stroke patients, 100 well controls, and 100 ill controls. Hospitals in Canada, the USA and Australia are participating in this study.
This study is funded by a grant from the National Institutes of Health (NIH) and Neurological Disorders and Stroke (NINDS).